NIDDK News

News and events from NIDDK-funded research and programs.

Media Inquiries

Latest News

A child is sitting on a step reading data on his artificial pancreas device. Description: A clinical trial at four pediatric diabetes centers in the United States has found that a new artificial pancreas system — which automatically monitors and regulates blood glucose levels — is safe and effective at managing blood glucose levels in children as young as age six with type 1 diabetes. The trial was funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health.

Artificial pancreas effectively controls type 1 diabetes in children age 6 and up

Aug. 26, 2020

Patient sits on exam table while he has bandages placed on the bottom of his foot

First-ever research network tackles diabetic foot complications

July 24, 2020

Chart displaying the affects of exercise on a molecular level.

NIH-funded study to recruit thousands of participants to reveal exercise impact at the molecular level

June 25, 2020

NIH launches analytics platform to harness nationwide COVID-19 patient data to speed treatments

June 15, 2020

NIH scientists develop blood test to help improve liver cancer screening

June 11, 2020

NIH releases strategic plan to accelerate nutrition research over next 10 years

May 27, 2020

Beige is all the Rage: Drug Treatment Stimulates Beige Fat Formation Resulting in Metabolic Health Benefits in People with Obesity

May 1, 2020

NIH announces $1 million prize competition to target global disease diagnostics

Feb. 26, 2020

Diabetes Continues To Rise Among American Youth

Feb. 14, 2020

Putting the “Brakes” on Adult Blood Stem Cell Proliferation

Feb. 13, 2020

New Mouse Model Mimics Celiac Disease in People

Feb. 12, 2020

View all News

More News

For Reporters

NIDDK's Press Team can provide access to researchers and program staff and guide you to the latest information and research on diabetes, obesity, and digestive and kidney diseases from NIDDK.

Twitter, Facebook, YouTube, and Instagram icons

Follow us on Twitter, Facebook, YouTube, and Instagram for health information and the latest updates about the Institute’s initiatives, events, research, and funding opportunities.

Newsletters

The NIDDK Director

Griffin P. Rodgers, M.D., M.A.C.P.

Dr. Rodgers in the News

Photo of NIDDK Director Dr. Griffin Rodgers. — NIDDK Director Dr. Griffin P. Rodgers discusses COVID-19 pandemic recovery plans for NIDDK research.

Dr. Rodgers joins Erica Campbell's radio show to discuss how COVID-19 is affecting the African American community. (MP3, 12.65 MB)
Dr. Rodgers and NHLBI Director Dr. Gary Gibbons take part in a livestream on their JAMA editorial on obesity, hypertension and COVID-19 in communities of color.
Dr. Rodgers served as a panelist in an NHLBI-hosted workshop on sickle cell disease for Black media, including the Indianapolis Recorder.
Dr. Rodgers and Dr. John Tisdale are selected as 2020 Samuel J. Heyman Service to America Medal finalists for sickle cell research.